Long-Term Pentoxifylline Therapy Is Associated with a Reduced Risk of Atherosclerotic Cardiovascular Disease by Inhibiting Oxidative Stress and Cell Apoptosis in Diabetic Kidney Disease Patients

Long-Term Pentoxifylline Therapy Is Associated with a Reduced Risk of Atherosclerotic Cardiovascular Disease by Inhibiting Oxidative Stress and Cell Apoptosis in Diabetic Kidney Disease Patients

There is limited understanding of the optimal duration and dosage of pentoxifylline (PTX) therapy required to achieve significant reductions in atherosclerotic cardiovascular disease (ASCVD) risk, particularly in patients with diabetic kidney disease (DKD). This study aimed to evaluate the impact of...

Full description

Saved in:
Bibliographic Details
Main Authors: Jie-Sian Wang, Ping-Hsuan Tsai, Kuo-Feng Tseng, Cheng-Li Lin, Fang-Yu Chen, Chiz-Tzung Chang, Ming-Yi Shen
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Antioxidants
Subjects:
atherosclerotic cardiovascular disease
diabetes mellitus
chronic kidney disease
pentoxifylline
apoptosis
Online Access:https://www.mdpi.com/2076-3921/13/12/1471
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2076-3921/13/12/1471

Similar Items